In vitro susceptibility of fluconazole-resistant strains of Candida albicans to itraconazole
Tiballi, R.; He, X.; Zarins, L.; Sangeorzan, J.; Bradley, S.; Kauffman, C.
Abstracts of the General Meeting of the American Society for Microbiology 94: 607
1994
ISSN/ISBN: 1060-2011
Accession: 031865416
PDF emailed within 1 workday: $29.90
Related References
Paugam, A.; Lassal, H.; Tourte Schaefer, C.; Dupouy Camet, J. 1996: Study of in vitro susceptibility to fluconazole and itraconazole of 25 Candida albicans strains isolated in a hospital laboratory Journal de Mycologie Medicale 6(3): 149Jiang-Wei-Su; Tan-Sheng-Shun; Jiang-Guo-Ying; Chen-Qing-Xiu 2006: Synergisic effects of terbinafine combined with fluconazole or itraconazole on stable fluconazole-resistant Candida albicans induced by fluconazole in vitro Zhonghua Weishengwuxue He Mianyixue Zazhi 26(4): 360-364
D'Auria, F.D.; Tecca, M.; Strippoli, R.; Simonetti, N. 2001: In vitro activity of propyl gallate-azole drug combination against fluconazole- and itraconazole-resistant Candida albicans strains Letters in Applied Microbiology 32(4): 220-223
Arevalo, M.P.; Arias, A.; Andreu, A.; Sierra, A. 1992: In vitro susceptibility versus amphotericin B, fluconazole, and itraconazole of 278 isolates of Candida albicans Revista Iberoamericana de Micologia 9(4): 94-96
Le Guennec, R.; Reynes, J.; Mallié, M.; Pujol, C.; Janbon, F.; Bastide, J.M. 1995: Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities Journal of Clinical Microbiology 33(10): 2732-2737
Barchiesi, F.; Falconi Di Francesco, L.; Scalise, G. 1997: In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles Antimicrobial Agents and ChemoTherapy 41(8): 1812-1814
Velegraki, A. 1995: In vitro susceptibility to itraconazole and fluconazole of switch phenotypes of Candida albicans serotypes A and B, isolated from immunocompromised hosts Journal of Medical and Veterinary Mycology: Bi-Monthly Publication of the International Society for Human and Animal Mycology 33(1): 83-85
Cetinkaya, Z.; Kiraz, N. 2005: In vitro investigation of antifungal activities of phenotypic variation Candida albicans strains against fluconazole, itraconazole and voriconazole Nihon Ishinkin Gakkai Zasshi 46(3): 197-201
Martinez-Suarez, J.V.; Rodriguez-Tudela, J.L. 1995: Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain Antimicrobial Agents and ChemoTherapy 39(7): 1512-1516
Eloy, O.; Lemaire, P.; Roubache, J.F.; Pina, P.; Favre, A.; Chenard, C.; Decousser, J.W.; Belan, A.G.; Ghnassia, J.C. 1998: Acquisition de la résistance aux azoles de Candida albicans au cours de candidoses oropharyngées chez le sujet VIH+ : Intérêt du typage moléculaire - Variations in fluconazole and itraconazole susceptibility and DNA subtyping of Candida albicans isolated from patients with AIDS and oral candidiasis Journal de Mycologie Medicale (Paris) 8(2): 78-82
Martinez, M.A.; Gutierrez, M.J.; Aller, A.I.; Montero, O.; Morilla, D.; Bernal, S.; Martin-Mazuelos, E. 1997: In vitro susceptibility of itraconazole against fluconazole resistant and susceptible Candida spp. isolates from oral cavities of HIV infected patients Journal de Mycologie Medicale 7(3): 123-127
Barchiesi, F.; Colombo, A.L.; McGough, D.A.; Fothergill, A.W.; Rinaldi, M.G. 1994: In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus Antimicrobial Agents and ChemoTherapy 38(7): 1530-1533
Lo, W.-H.; Deng, F.-S.; Chang, C.-J.; Lin, C.-H. 2020: Synergistic Antifungal Activity of Chitosan with Fluconazole against Candida albicans, Candida tropicalis, and Fluconazole-Resistant Strains Molecules 25(21)
St Germain, G.; Dion, C.; De Repentigny, L. 1993: In vitro susceptibility to ketoconazole and itraconazole of 257 strains of Candida albicans isolated from HIV-positive patients Abstracts of the General Meeting of the American Society for Microbiology 93: 11
Ruhnke, M.; Mueller, F.M.; Schneider, U.; Adler, A. 1999: Replacement of fluconazole-resistant Candida albicans strains by fluconazole-sensitive strains after initiation of HAART therapy for HIV infection Mycoses 42(3): 205